Discovery of GSBR-1290, a Highly Potent, Orally Available, Novel Small Molecule GLP-1 Receptor Agonist

被引：1
|
作者：
Mao, Ting
Meng, Qinghua
Zhang, Haizhen
Zhang, Jinqiang J.
Shi, Songting
Guan, Zhibo
Jiang, Xinglong
Zhang, Fang
Lei, Hui
Lin, Xichen
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-760-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
760-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] An Orally Active Allosteric GLP-1 Receptor Agonist Is Neuroprotective in Cellular and Rodent Models of Stroke
    Zhang, Huinan
    Liu, Yunhan
    Guan, Shaoyu
    Qu, Di
    Wang, Ling
    Wang, Xinshang
    Li, Xubo
    Zhou, Shimeng
    Zhou, Ying
    Wang, Ning
    Meng, Jingru
    Ma, Xue
    PLOS ONE, 2016, 11 (02):
  • [32] Discovery of orally available and highly efficacious small molecule BACE inhibitors for Alzheimer's disease
    Zhong, Wenge
    Brown, Jim
    Brown, Ryan
    Cheng, Yuan
    Croghan, Michael
    Dineen, Tom
    Graceffa, Russell
    Harried, Scott
    Hitchcock, Stephen
    Horne, Daniel
    Huang, Hongbing
    Hungate, Randall W.
    Imbeah-Ampiah, Ronke
    Judd, Ted
    Kaller, Matt
    Kreiman, Chuck
    La, Dan
    Lopez, Patricia
    Monenschein, Holger
    Nguyen, Tom
    Patel, Vinod
    Pennington, Lew
    Weiss, Matt
    Xue, May
    Yang, Bryant
    Albrecht, Brian
    Masse, Craig
    Bartberger, Michael
    Jordan, Steven
    Hansen, Karl
    Tedrow, Jason
    Dunn, Robert
    Vargas, Hugo
    Williamson, Toni
    Fremeau, Robert
    Treanor, James
    Kiang, Yuan-Hon
    Hickman, Dean
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [33] Discovery of a novel potent peptide agonist to adiponectin receptor 1
    Kim, Sunghwan
    Lee, Younho
    Kim, Jun Woo
    Son, Young-Jin
    Ma, Min Jung
    Um, Jee-Hyun
    Kim, Nam Doo
    Min, Sang Hyun
    Kim, Dong Il
    Kim, Brian B.
    PLOS ONE, 2018, 13 (06):
  • [34] A phase 1, randomised, double-blind trial of the safety, tolerability, pharmacokinetics, and pharmacodynamics of oral small molecule GSBR-1290 in Japanese and non-Japanese healthy volunteers
    Coll, B.
    Seman, L. J.
    Yue, H.
    Barth, A.
    Ibarra, L.
    Bach, M.
    DIABETOLOGIA, 2024, 67 : S359 - S359
  • [35] DISCOVERY OF A HIGHLY POTENT AND ORALLY AVAILABLE OREXIN 2 RECEPTOR-SELECTIVE AGONIST, TAK-861, AS A NOVEL THERAPEUTIC AGENT FOR NARCOLEPSY AND OTHER HYPERSOMNIA DISORDERS
    Kimura, H.
    Terada, M.
    Yamada, R.
    Kajita, Y.
    Koike, T.
    Mitsukawa, K.
    SLEEP MEDICINE, 2024, 115 : 16 - 16
  • [36] The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Transiently Delays Gastric Emptying Similarly to a Selective Long-Acting GLP-1 Receptor Agonist
    Urva, Shweta
    Nauck, Michael A.
    Coskun, Tamer
    Cui, Xuewei
    Haupt, Axel
    Benson, Charles
    Loghin, Corina
    DIABETES, 2019, 68
  • [37] The novel dual GIP and GLP-1 receptor agonist, tirzepatide, transiently delays gastric emptying similarly to a selective long-acting GLP-1 receptor agonist
    Urva, S.
    Nauck, M. A.
    Coskun, T.
    Cui, X.
    Haupt, A.
    Benson, C. T.
    Loghin, C.
    DIABETOLOGIA, 2019, 62 : S58 - S58
  • [38] Novel Site-Specific Fatty Chain-Modified GLP-1 Receptor Agonist with Potent Antidiabetic Effects
    Zhong, Xia
    Chen, Zhu
    Chen, Qiong
    Zhao, Wei
    Chen, Zhi
    MOLECULES, 2019, 24 (04):
  • [39] A Novel Peptide with Similar Pharmacology to Exenatide in Rodents as GLP-1 Receptor Agonist
    Guangji Zhang
    Licheng Wang
    Jia Xu
    Yue Zhang
    Mingyang Wang
    Qifei Wang
    Kai Wang
    Liping Wang
    International Journal of Peptide Research and Therapeutics, 2018, 24 : 271 - 278
  • [40] A Novel Peptide with Similar Pharmacology to Exenatide in Rodents as GLP-1 Receptor Agonist
    Zhang, Guangji
    Wang, Licheng
    Xu, Jia
    Zhang, Yue
    Wang, Mingyang
    Wang, Qifei
    Wang, Kai
    Wang, Liping
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2018, 24 (02) : 271 - 278
12345